Real-time signals on 30+ pharmaceutical assets. Track sentiment shifts, safety events, and supply disruptions before they hit earnings.
We aggregate multiple data sources to detect narrative shifts early.
Track acceleration in public search interest. Sudden spikes often precede news events and earnings surprises.
FDA FAERS adverse event data quantified into actionable risk scores. Know about safety clusters before they trend.
Early detection of lawsuit chatter, class action mentions, and legal news across web sources.
Monitor shortage complaints, backorder discussions, and availability issues in real-time.
Track non-clinical usage trends that drive revenue growth but increase regulatory scrutiny.
Z-score analysis against rolling baselines. Get alerted when activity deviates from normal patterns.
Real data from authoritative sources—not LLM guesses.
Normalized search interest data. Real volume, not estimates.
Official adverse event reports from the FDA's public database.
News and forum mentions via Google Search API.
GLP-1 agonists, CNS stimulants, research peptides, and biosimilars.
We're onboarding select institutional partners for our pilot program.